Back to Agenda
Session 5: The Pricing and Reimbursement Perspective
Speaker(s)
Alexander Natz, JD
Secretary General, European Confederation of Pharmaceutical Entrepreneurs, Belgium
Status quo of ATMP Launches in Europe
Helen Knight
Programme Director, National Institute for Health and Care Excellence (NICE), United Kingdom
ATMPs from the HTA Viewpoint – Learnings until now
Michela Gabaldo, PharmD, MSc
VP ATMP Global Regulatory Affairs, Evotec, Italy
Payer Considerations
Have an account?
